A Targeted Approach for Congenital Cytomegalovirus Screening Within Newborn Hearing Screening

Overview

Journal Pediatrics

Specialty Pediatrics

Date 2017 Jan 4

PMID 28049114

Citations 71

Authors

Karen B Fowler

Faye P McCollister

Diane L Sabo

Angela G Shoup

Kris E Owen

Julie L Woodruff

Edith Cox

Lisa S Mohamed

Daniel I Choo

Suresh B Boppana

Affiliations

Soon will be listed here.

Abstract

Background And Objective: Congenital cytomegalovirus (cCMV) infection remains a leading cause of childhood hearing loss. Currently universal CMV screening at birth does not exist in the United States. An alternative approach could be testing infants who do not pass their newborn hearing screening (NHS) for cCMV. This study was undertaken to evaluate whether a targeted approach will identify infants with CMV-related sensorineural hearing loss (SNHL).

Methods: Infants born at 7 US medical centers received NHS and were also screened for cCMV while in the newborn nursery. Infants who tested positive for CMV received further diagnostic audiologic evaluations to identify or confirm hearing loss.

Results: Between 2007 and 2012, 99 945 newborns were screened for both hearing impairment and cCMV. Overall, 7.0% of CMV-positive infants did not pass NHS compared with 0.9% of CMV-negative infants (P < .0001). Among the cCMV infants who failed NHS, diagnostic testing confirmed that 65% had SNHL. In addition, 3.6% of CMV-infected infants who passed their NHS had SNHL confirmed by further evaluation during early infancy. NHS in this cohort identified 57% of all CMV-related SNHL that occurred in the neonatal period.

Conclusions: A targeted CMV approach that tests newborns who fail their NHS identified the majority of infants with CMV-related SNHL at birth. However, 43% of the infants with CMV-related SNHL in the neonatal period and cCMV infants who are at risk for late onset SNHL were not identified by NHS.

Citing Articles

Agreement Between Dried Blood Spot and Plasma PCR in Infants With Congenital Cytomegalovirus Infection.

Shimamura M, Kim J, Medoro A, Flint K, Kaptsan I, Wang H J Med Virol. 2025; 97(3):e70257.

PMID: 40035472 PMC: 11877996. DOI: 10.1002/jmv.70257.

Congenital cytomegalovirus screening in neonates born after 35 weeks gestation-is targeted screening beneficial?.

Aldon M, Raveentheran G, Amin Z, Chan S, Aoyama R, Tee N Front Pediatr. 2025; 13:1510612.

PMID: 40017708 PMC: 11865022. DOI: 10.3389/fped.2025.1510612.

Timing of congenital cytomegalovirus diagnosis and missed opportunities.

Baker M, Wang X, Melvin A Front Pediatr. 2025; 13:1475121.

PMID: 39967745 PMC: 11832646. DOI: 10.3389/fped.2025.1475121.

American Cochlear Implant Alliance Position Statement on Newborn Congenital Cytomegalovirus Screening.

Pesch M, Brown K, Birath A, Demmler-Harrison G, Sapp C, Selleck A Otolaryngol Head Neck Surg. 2024; 172(2):728-733.

PMID: 39666828 PMC: 11773442. DOI: 10.1002/ohn.1079.

Auditory and Vestibular Involvement in Congenital Cytomegalovirus Infection.

Pinninti S, Britt W, Boppana S Pathogens. 2024; 13(11).

PMID: 39599572 PMC: 11597862. DOI: 10.3390/pathogens13111019.

References

Kennedy C, McCann D, Campbell M, Kimm L, Thornton R . Universal newborn screening for permanent childhood hearing impairment: an 8-year follow-up of a controlled trial. Lancet. 2005; 366(9486):660-2. DOI: 10.1016/S0140-6736(05)67138-3. View

Dahle A, Fowler K, Wright J, Boppana S, Britt W, Pass R . Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol. 2000; 11(5):283-90. View

Young N, Reilly B, Burke L . Limitations of universal newborn hearing screening in early identification of pediatric cochlear implant candidates. Arch Otolaryngol Head Neck Surg. 2011; 137(3):230-4. DOI: 10.1001/archoto.2011.4. View

van der Sande M, Kaye S, Miles D, Waight P, Jeffries D, Ojuola O . Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort. PLoS One. 2007; 2(6):e492. PMC: 1876257. DOI: 10.1371/journal.pone.0000492. View

Stehel E, Shoup A, Owen K, Jackson G, Sendelbach D, Boney L . Newborn hearing screening and detection of congenital cytomegalovirus infection. Pediatrics. 2008; 121(5):970-5. DOI: 10.1542/peds.2006-3441. View

Johnson J, White K, Widen J, Gravel J, James M, Kennalley T . A multicenter evaluation of how many infants with permanent hearing loss pass a two-stage otoacoustic emissions/automated auditory brainstem response newborn hearing screening protocol. Pediatrics. 2005; 116(3):663-72. DOI: 10.1542/peds.2004-1688. View

Fowler K, Stagno S, Pass R . Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980-1990. J Infect Dis. 1993; 168(3):552-6. DOI: 10.1093/infdis/168.3.552. View

Boppana S, Ross S, Shimamura M, Palmer A, Ahmed A, Michaels M . Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med. 2011; 364(22):2111-8. PMC: 3153859. DOI: 10.1056/NEJMoa1006561. View

Fowler K, McCollister F, Dahle A, Boppana S, Britt W, Pass R . Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr. 1997; 130(4):624-30. DOI: 10.1016/s0022-3476(97)70248-8. View

10.

Barbi M, Binda S, Caroppo S, Ambrosetti U, Corbetta C, Sergi P . A wider role for congenital cytomegalovirus infection in sensorineural hearing loss. Pediatr Infect Dis J. 2003; 22(1):39-42. DOI: 10.1097/00006454-200301000-00012. View

11.

Cannon M . Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol. 2009; 46 Suppl 4:S6-10. DOI: 10.1016/j.jcv.2009.09.002. View

12.

Goderis J, De Leenheer E, Smets K, Van Hoecke H, Keymeulen A, Dhooge I . Hearing loss and congenital CMV infection: a systematic review. Pediatrics. 2014; 134(5):972-82. DOI: 10.1542/peds.2014-1173. View

13.

Kimberlin D, Jester P, Sanchez P, Ahmed A, Arav-Boger R, Michaels M . Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med. 2015; 372(10):933-43. PMC: 4401811. DOI: 10.1056/NEJMoa1404599. View

14.

Larke R, Wheatley E, Saigal S, Chernesky M . Congenital cytomegalovirus infection in an urban Canadian community. J Infect Dis. 1980; 142(5):647-53. DOI: 10.1093/infdis/142.5.647. View

15.

. Year 2007 position statement: Principles and guidelines for early hearing detection and intervention programs. Pediatrics. 2007; 120(4):898-921. DOI: 10.1542/peds.2007-2333. View

16.

Fowler K, Stagno S, Pass R, Britt W, Boll T, Alford C . The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med. 1992; 326(10):663-7. DOI: 10.1056/NEJM199203053261003. View

17.

Ross D, Holstrum W, Gaffney M, Green D, Oyler R, Gravel J . Hearing screening and diagnostic evaluation of children with unilateral and mild bilateral hearing loss. Trends Amplif. 2008; 12(1):27-34. PMC: 4111446. DOI: 10.1177/1084713807306241. View

18.

Dollard S, Grosse S, Ross D . New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007; 17(5):355-63. DOI: 10.1002/rmv.544. View

19.

Fowler K, Boppana S . Congenital cytomegalovirus (CMV) infection and hearing deficit. J Clin Virol. 2006; 35(2):226-31. DOI: 10.1016/j.jcv.2005.09.016. View

20.

Ahlfors K, Ivarsson S, Harris S, Svanberg L, Holmqvist R, Lernmark B . Congenital cytomegalovirus infection and disease in Sweden and the relative importance of primary and secondary maternal infections. Preliminary findings from a prospective study. Scand J Infect Dis. 1984; 16(2):129-37. DOI: 10.3109/00365548409087131. View